Marco Gobbi

12.8k total citations · 1 hit paper
270 papers, 9.1k citations indexed

About

Marco Gobbi is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, Marco Gobbi has authored 270 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Molecular Biology, 70 papers in Cellular and Molecular Neuroscience and 54 papers in Immunology. Recurrent topics in Marco Gobbi's work include Neuroscience and Neuropharmacology Research (55 papers), Chronic Lymphocytic Leukemia Research (47 papers) and Alzheimer's disease research and treatments (29 papers). Marco Gobbi is often cited by papers focused on Neuroscience and Neuropharmacology Research (55 papers), Chronic Lymphocytic Leukemia Research (47 papers) and Alzheimer's disease research and treatments (29 papers). Marco Gobbi collaborates with scholars based in Italy, United States and United Kingdom. Marco Gobbi's co-authors include Tiziana Mennini, Mario Salmona, Marten Beeg, Matteo Stravalaci, George Janossy, M Bofill, Mara Canovi, Silvio Garattini, Gianluigi Forloni and Annamaria Vezzani and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Marco Gobbi

265 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia.

1982 400 citations Marco Gobbi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marco Gobbi Italy	50	3.5k	1.9k	1.9k	1.8k	1.1k	270	9.1k
Soo Young Choi South Korea	52	4.9k 1.4×	1.3k 0.7×	968 0.5×	1.3k 0.7×	477 0.4×	521	11.1k
Thomas Franke United States	36	11.8k 3.4×	1.9k 1.0×	2.1k 1.1×	2.2k 1.2×	2.4k 2.2×	49	17.6k
Kaoru Saijo Japan	33	3.2k 0.9×	1.3k 0.7×	3.1k 1.6×	1.2k 0.7×	1.2k 1.1×	76	9.1k
Barbara S. Slusher United States	58	7.2k 2.1×	2.7k 1.4×	1.6k 0.8×	1.7k 1.0×	2.4k 2.2×	316	15.4k
Swapan K. Ray United States	57	4.9k 1.4×	1.8k 0.9×	821 0.4×	823 0.5×	983 0.9×	213	10.1k
Craig J. Thomas United States	61	7.0k 2.0×	1.8k 0.9×	2.1k 1.1×	828 0.5×	1.6k 1.5×	250	15.2k
Anne N. Murphy United States	60	8.3k 2.3×	953 0.5×	1.1k 0.6×	2.5k 1.4×	1.0k 0.9×	130	13.2k
Kirk W. Johnson United States	46	2.6k 0.7×	1.6k 0.8×	730 0.4×	2.1k 1.2×	483 0.4×	137	7.6k
Young‐Myeong Kim South Korea	67	7.7k 2.2×	964 0.5×	2.5k 1.3×	3.0k 1.7×	1.2k 1.1×	358	16.4k
Ken Arai United States	63	4.8k 1.4×	1.2k 0.6×	1.6k 0.8×	961 0.5×	606 0.5×	238	11.8k

Countries citing papers authored by Marco Gobbi

Since Specialization

Citations

This map shows the geographic impact of Marco Gobbi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Gobbi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Gobbi more than expected).

Fields of papers citing papers by Marco Gobbi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marco Gobbi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Gobbi. The network helps show where Marco Gobbi may publish in the future.

Co-authorship network of co-authors of Marco Gobbi

This figure shows the co-authorship network connecting the top 25 collaborators of Marco Gobbi. A scholar is included among the top collaborators of Marco Gobbi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marco Gobbi. Marco Gobbi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rossi, Roberta, Barbara Bigerna, Marco Gentili, et al.. (2024). Artificial Intelligence-Powered Molecular Docking and Steered Molecular Dynamics for Accurate scFv Selection of Anti-CD30 Chimeric Antigen Receptors. International Journal of Molecular Sciences. 25(13). 7231–7231. 9 indexed citations

Cattaneo, Irene, Rut Valgardsdottir, Muriel Roth, et al.. (2024). Development of a Bispecific IgG1 Antibody Targeting BCMA and PDL1. Antibodies. 13(1). 15–15. 1 indexed citations

Beeg, Marten, et al.. (2024). The Detection of Toxic Amyloid-β Fibril Fragments Through a Surface Plasmon Resonance Immunoassay. International Journal of Molecular Sciences. 25(23). 13020–13020. 2 indexed citations

Magliocca, Aurora, Carlo Perego, F. Motta, et al.. (2023). Indoleamine 2,3-Dioxygenase Deletion to Modulate Kynurenine Pathway and to Prevent Brain Injury after Cardiac Arrest in Mice. Anesthesiology. 139(5). 628–645. 4 indexed citations

Gobbi, Marco, et al.. (2023). Acute Promyelocytic Leukemia and Brugada Syndrome: A Report on the Safety of Arsenic Trioxide/All-Trans-Retinoic Acid Therapy. SHILAP Revista de lepidopterología. 15(3). 440–447. 2 indexed citations

Beeg, Marten, Sara Baroni, Ada De Luigi, et al.. (2023). A Comprehensive Technology Platform for the Rapid Discovery of Peptide Inhibitors against SARS-CoV-2 Pseudovirus Infection. International Journal of Molecular Sciences. 24(15). 12146–12146. 1 indexed citations

Freeman, Ciara L., Sebastian Böttcher, Javier de la Serna, et al.. (2018). Tocilizumab to Prevent Infusion-Related Events in Patients with Chronic Lymphocytic Leukemia and Co-Morbidities Treated with Obinutuzumab and Chlorambucil: Results from the Randomized Phase Ib GALACTA Trial. Blood. 132(Supplement 1). 4419–4419. 1 indexed citations

Steurer, Michael, Lydia Scarfò, Marco Montillo, et al.. (2014). INTERIM RESULTS FROM A PHASE IIA STUDY OF THE ANTI-CXCL12 SPIEGELMER OLAPTESED PEGOL (NOX-A12) IN COMBINATION WITH BENDAMUSTINE/RITUXIMAB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. Haematologica. 99. 59–59. 2 indexed citations

Montagna, G. La, Laura Obici, C. Uggetti, et al.. (2013). Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis. Amyloid. 20(3). 173–178. 21 indexed citations

10.

Biasini, Emiliano, Matteo Stravalaci, Alessandra Sclip, et al.. (2013). An N-terminal Fragment of the Prion Protein Binds to Amyloid-β Oligomers and Inhibits Their Neurotoxicity in Vivo. Journal of Biological Chemistry. 288(11). 7857–7866. 156 indexed citations

11.

Noè, Francesco M., Jari Nissinen, Asla Pitkänen, et al.. (2006). Gene therapy in epilepsy: The focus on NPY. Peptides. 28(2). 377–383. 41 indexed citations

12.

Anguita, Eduardo, et al.. (2005). Is there a role for CTCF binding sites in regulating the structure or function of the a globin gene cluster. Blood Cells Molecules and Diseases. 34. 75–75. 1 indexed citations

13.

Bozzi, Yuri, Cristina Richichi, Alessandro Viegi, et al.. (2005). Antiepileptic Effects of Botulinum Neurotoxin E. Journal of Neuroscience. 25(8). 1943–1951. 80 indexed citations

14.

Fra, Annamaria, Massimo Locati, Karel Otero, et al.. (2003). Cutting Edge: Scavenging of Inflammatory CC Chemokines by the Promiscuous Putatively Silent Chemokine Receptor D6. The Journal of Immunology. 170(5). 2279–2282. 166 indexed citations

15.

Santini, Gino, S Nati, Mauro Spriano, et al.. (2001). Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma.. CINECA IRIS Institutial Research Information System (University of Genoa). 86(3). 282–6. 24 indexed citations

16.

Tazzari, Pier Luigi, Daniela de Totero, Andrea Bolognesi, et al.. (1999). An Epstein-Barr virus-infected lymphoblastoid cell line (D430B) that grows in SCID-mice with the morphologic features of a CD30+ anaplastic large cell lymphoma, and is sensitive to anti-CD30 immunotoxins.. PubMed. 84(11). 988–95. 26 indexed citations

17.

Gobbi, Marco, Emanuela Frittoli, & Tiziana Mennini. (1993). Further Studies on α2-Adrenoceptor Subtypes Involved in the Modulation of [3H]Noradrenaline and [3H]5-Hydroxytryptamine Release from Rat Brain Cortex Synaptosomes. Journal of Pharmacy and Pharmacology. 45(9). 811–814. 13 indexed citations

18.

Mennini, Tiziana, et al.. (1989). Noise-induced opposite changes in central and peripheral benzodiazepine receptors in rat brain cortex. Neuroscience Research Communications. 5(1). 27–34. 12 indexed citations

19.

Gobbi, Marco, Pier Luigi Tazzari, Donatella Raspadori, et al.. (1985). Meningeal Leukemia Complicating Prolymphocytoid Transformation of B-Chronic Lymphocytic Leukemia. Acta Haematologica. 74(4). 205–207. 13 indexed citations

20.

Varotti, C, Antonellá Tosti, Marco Gobbi, Giovanni Martinelli, & Annalisa Patrizi. (1982). Eosinophilic Cellulitis: A New Case. Dermatology. 164(6). 404–406. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact